Hashtag
The Times

Sapu Nano Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

SAN DIEGO, US - Media OutReach Newswire - 9 July 2026 - Sapu Nano (US) LLC, a clinical-stage biotechnology company developing the proprietary Deciparticle™ nanomedicine platform, today announced that the independent Safety Review Committee (SRC) has completed its review of the initial safety cohort in the Company's ongoing SP-03-B101 Phase 1b clinical trial evaluating Sapu003, an investigational intravenous formulation of everolimus.



Following completion of the protocol-defined 28-day dose-limiting toxicity (DLT) evaluation period for the initial three-patient cohort, the SRC concluded that no dose-limiting toxicities were observed and recommended advancing the study to the next planned dose level. Enrollment into the second dose cohort has commenced.

SP-03-B101 is an open-label, multicenter, Bayesian Optimal Interval (BOIN) dose-escalation study evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of weekly intravenous Sapu003 in patients with advanced mTOR-sensitive solid tumors. The study is registered on ClinicalTrials.gov (Identifier: NCT07369505).

Following successful completion of the initial safety cohort, the Company has initiated expansion of the SP-03-B101 clinical program into Europe, broadening patient access and supporting the global clinical development strategy for Sapu003.

"The independent Safety Review Committee's recommendation to advance to the next dose level provides important clinical validation of the Sapu003 program," said Dr. Vuong Trieu, Chief Executive Officer of Sapu Nano. "Combined with the expansion of SP-03-B101 into Europe, these milestones position Sapu003 for accelerated clinical development while broadening access for patients with advanced mTOR-sensitive solid tumors."

Peer-Reviewed Publication Supports Clinical Development

The clinical milestone follows the Company's recent peer-reviewed publication describing the scientific foundation of Sapu003 and the Deciparticle™ platform:

Min SH, Forero K, Putnam W, Anderson J, Hoff R, Lopp J, Trieu V, Ho K, Lee C. Intravenous Everolimus Formulation (Sapu003) for Clinical Trials. International Journal of Molecular Sciences. 2026;27(13):5775. doi: 10.3390/ijms27135775.

The publication provides the first comprehensive description of the Deciparticle™ platform and describes a stable intravenous everolimus nanoparticle formulation with a mean particle size below 20 nanometers, identification of mPEG-Chol as the optimal carrier, a scalable cGMP manufacturing process suitable for clinical production, and potent preclinical antitumor activity.

Clinical Trial Information

Study Title: SP-03-B101: A Phase 1b Study of Sapu003 (Intravenous Everolimus) in Patients with Advanced mTOR-Sensitive Solid Tumors

ClinicalTrials.gov Identifier: NCT07369505

About Sapu003

Sapu003 is an investigational intravenous formulation of everolimus developed using Sapu Nano's proprietary Deciparticle™ nanoparticle platform. Sapu003 is designed to overcome the formulation limitations associated with oral everolimus by enabling intravenous administration with a scalable cGMP manufacturing process. The program is currently being evaluated in the Phase 1b SP-03-B101 clinical trial in patients with advanced mTOR-sensitive solid tumors.

About Sapu Nano's Deciparticle™

Sapu Nano's Deciparticle™ is a proprietary nanomedicine platform designed to formulate highly water-insoluble therapeutics into ultra-small nanoparticles for intravenous administration. The platform utilizes amphiphilic polymer architectures intended to improve aqueous compatibility, stability, manufacturability, and translational flexibility across multiple therapeutic classes.



Hashtag: #SapuNano

The issuer is solely responsible for the content of this announcement.

About Sapu Nano

Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug delivery, enhance therapeutic index, and unlock new clinical potential for established and novel therapeutics, with a primary focus in oncology. For more information, visit www.sapunano.com.

Business News

How Condition Based Monitoring Supports Better Equipment Maintenance

Moving Beyond Fixed Maintenance Intervals Condition based monitoring gives maintenance teams a way to assess equipment according to its actual operating condition rather than relying only on predet...

Hashtag.net.au - avatar Hashtag.net.au

Choosing Reliable Movers Melbourne Households Can Depend On

Moving home involves much more than transporting furniture from one address to another. The right movers Melbourne households choose can help organise the practical details, from collection and transp...

Hashtag.net.au - avatar Hashtag.net.au

Google's New Online Estimates Could Be Bad for Businesses and Customers

Google's AI-powered pricing feature allows users to request pricing information from businesses, making it easier to compare estimates. While this may save customers time, it also raises concerns abou...

Hashtag.net.au - avatar Hashtag.net.au

From Warehouse to Hotspot: Why Brisbane's Breweries, Gyms and Cafés Love Industrial Epoxy Flooring

Walk through Newstead, Teneriffe, West End or Fortitude Valley and you'll notice a pattern. Old warehouses, workshops and factories are being transformed into craft breweries, specialty cafés, bouti...

Hashtag.net.au - avatar Hashtag.net.au

Custom Packaging Ideas to Discuss With a Cardboard Box Manufacturer

Build Packaging Around the Way Products Move Packaging has to work through the full movement of a product, from packing and storage to delivery or retail display. A cardboard box manufacturer can h...

Hashtag.net.au - avatar Hashtag.net.au

How Disability Service Providers Can Support Individual Goals

Disability service providers can play an important role in helping people access practical assistance while maintaining choice, independence and participation in everyday life. The most useful suppo...

Hashtag.net.au - avatar Hashtag.net.au

Health & Wellness

Looking After a Hearing Aid: The Small Daily Habits That Matter

Hashtag.net.au - avatar Hashtag.net.au

A hearing aid is a small electronic device worn close to skin, sweat and earwax, and it needs regular care to keep working as it should. Most of that care is simple and takes only a minute or two, b...

What to Look for When Choosing a Dental Clinic Melbourne Patients Can Rely On

Hashtag.net.au - avatar Hashtag.net.au

Look at the Range of Dental Care Available Choosing a dental practice is easier when patients can access different types of care in one place. A dental clinic Melbourne patients visit may provide gen...

What Do Clinical Teams Need from Their Surgical Supply Partners?

Hashtag.net.au - avatar Hashtag.net.au

In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...

hacklink esim usazlibraryzlibrarySahabetnot on gamestopuk casinos not on gamstopcasino siteleriseo ajansıyurtdışı turseo danışmanlığıjojobetjojobet girişjojobetviagra 100 mg fiyatjojobetcasibommarsbahis